Cross validation of the Turkish version of dermatology life quality index

International Journal of Dermatology

Volumn 45, Issue 11, 2006, Pages 1300-1307

  Öztürkcan, Serap ^a,b   Ermertcan, Aylin Türel ^a   Eser, Erhan ^a   Turhan Şahin, Mustafa ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ADULT; ALOPECIA AREATA; ARTICLE; CHRONIC URTICARIA; COGNITION; CONTACT DERMATITIS; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DERMATOLOGY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HUMAN; INTERNAL CONSISTENCY; LINGUISTICS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; OUTPATIENT; PRINCIPAL COMPONENT ANALYSIS; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; RANK SUM TEST; RELIABILITY; SCORING SYSTEM; SHORT FORM 36; STATISTICAL ANALYSIS; STUDENT T TEST; TINEA; TURKEY (REPUBLIC); VALIDATION PROCESS;

ADOLESCENT; ADULT; DERMATOLOGY; HUMANS; LANGUAGE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SKIN DISEASES; TRANSLATIONS; TURKEY;

EID: 33750293777     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02881.x     Document Type: Article

References (44)

1. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med 1996; 334: 833-840.
2. Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Intern Med 1993; 118: 622-629.
3. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
4. Köse O, Gür AR. Dermatolojide Yaşam Kalitesi ve ölçümü. Türkiye Klinikleri J Dermatol 2000; 10: 171-174.
5. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality of life measure for patients with skin disease: Reliability, validity and responsiveness. J Invest Dermatol 1996; 107: 707-713.
6. Guyatt GH, Jaeschke R, Feeny DH, et al. Measurement in clinical trials: choosing the right approach. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven Publishers, 1996: 41-48.
7. Ryan TJ. Disability in dermatology. Br J Hosp Med 1991; 46: 33-36.
8. Jowett S, Ryan T. Skin disease and handicap: An analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425-429.
9. Tunçer Ö. Dermatolojide psikosomatik yaklaşim. In: Oǧuz O, Serdaroǧlu S, eds. Dermatolojide gelişmeler-3. Istanbul: Doyman Matbaasi, 1998: 137-142.
10. Koo J. The psychosocial impact of acne: Patients' perceptions. J Am Acad Dermatol 1995; 32: S26-S30.
11. Başak PY. Sik görülen bazi deri hastaliklarinin yaşam kalitesi üzerindeki etkilerinin karşilaştirilmasi. Türkiye Klinikleri J Dermatol 2000; 10: 171-174.
12. Chren MM, Lasek RJ, Quinn LM, et al. Convergent and discriminant validity of a generic and disease specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997; 108: 103-107.
13. Finlay AY, Khan GK, Luscombe DK, et al. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990; 123: 751-756.
14. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. Br Med J 1996; 313: 919-921.
15. Gurel MS, Yanik M, Şimşek S, et al. Quality of life instrument for Turkish people with skin diseases. Int J Dermatol 2005; 44: 444-445.
16. Finlay AY. Quality of life measurement in dermatology: A practical guide. Br J Dermatol 1997; 136: 305-314.
17. Jayaprakasam A, Darvay A, Osborne G, et al. Comparison of assessments of severity and quality of life in cutaneous disease. Clin Exp Dermatol 2002; 27: 306-308.
18. De Tiedra AG, Mercadal J, Badia X, et al. Adaptación transcultural al Español del cuestionario Dermatology Life Quality Index (DLQI): El Índice de Calidad de Vida en Dermatologia. Actas Dermo-Sifiliograficas 1998; 89: 692-700.
19. Schafer T, Staudt A, Ring J. German instrument for the assessment of quality of life in skin diseases (DIELH). Internal consistency, reliability, convergent and discriminant validity and responsiveness. Hautarzt 2001; 52: 624-628.
20. Etemesi BA. Quality of life in Tanzanian adults with chronic skin disease. Ann Dermatol Venereol 2002; 129: 1S253.
21. Parsad D, Pandhi R, Dogra S, et al. Dermatology life quality index score in vitiligo and its impact on the treatment outcome. Br J Dermatol 2003; 148: 373-374.
22. Morgan M, McCreedy R, Simpson J, et al. Dermatology quality of life scales: A measurement of the impact of skin diseases. Br J Dermatol 1997; 136: 202-206.
23. Chren MM, Lasek RJ, Flocke SA, et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-1440.
24. Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: Clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol 1999; 141: 698-702.
25. Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: A comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672-676.
26. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998; 134: 454-458.
27. Aktan S, Ozmen E, Sanli B. Anxiety, depression and nature of acne vulgaris in adolescents. Int J Dermatol 2000; 39: 354-357.
28. Mohla G, Horvath N, Stevens S. Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis. J Am Acad Dermatol 1999; 40: 780-782.
29. Herd RM, Tidman MJ, Ruta DA, et al. Measurement of quality of life in atopic dermatitis: Correlation and validation of two different methods. Br J Dermatol 1997; 136: 502-507.
30. Finlay AY. Quality of life in atopic dermatitis. J Am Acad Dermatol 2001; 45: S64-S66.
31. Lewis VL, Finlay AY. Ten years experience of the Dermatology Life Quality Index (DLQI). J Invest Dermatol Symp Proc 2004; 9: 169-180.
32. Aghaei S, Sodaifi M, Jafari P, et al. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 2004; 4: 8.
33. Hahn HB, Melfi CA, Chuang TS, et al. Use of the Dermatology Life Quality Index (DLQI) in a Midwestern US urban clinic. J Am Acad Dermatol 2001; 45: 44-48.
34. Kent G, Al-Abadie MSK. Factors affecting responses on Dermatology Life Quality Index among vitiligo sufferers. Clin Exp Dermatol 1996; 21: 330-333.
35. Yazici K, Baz K, Yazici AE, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol 2004; 18: 435-439.
36. Roenigk RK, Roenigk HH. Sex differences in the psychological effects of psoriasis. Cutis 1978; 21: 529-533.
37. Narsico JC. Some psychological aspects of dermatoses. J Consult Clin Psychol 1952; 16: 199.
38. Muslin H. The emotional reaction to skin disease. Cutis 1972; 10: 211.
39. Rubinow DR, Peck GL, Squillace KM, et al. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17: 25-32.
40. Van der Meeren HLM, van der Schaar WW, van den Hurk CMAM. The psychological impact of severe acne. Cutis 1985; 36: 84-86.
41. Gupta MA. Psychosocial correlates of acne vulgaris. Dermatol Q 1989: 1-3.
42. Linnet J, Jemec GBE. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999; 140: 268-272.
43. Ware JE. How To Score The Revised MOS Short Form Health Scale (SF-36). Boston: The Health Institute New England Medical Center Hospitals, 1988.
44. Koçyiǧit H, Aydemir Ö, Ölmez N, et al. Kisa Form-36 (KF-36)'nin Türkçe Versiyonunun Güvenilirliǧi ve Geçerliliǧi. Ilaçve Tedavi Dergisi 1999; 12: 102-106.